NewAmsterdam Pharma News, NewAmsterdam Pharma Quote, NAMS Quote

NewAmsterdam Pharma (NQ:NAMS) Delayed: 20.94 -0.86 (3.94%)

Prev. Close

$21.80

Open

$21.71

52 Wk High

$0.00

52 Wk Low

$0.00

Day High

$22.24

Day Low

$20.65

P/E

N/A

EPS

$0.00

Volume

52,286

Friends, Peers and Foes (?): NAMSW REPL (more...)

Apr 19, 2024 04:21 PM Form 424B3 NewAmsterdam Pharma Co
Apr 18, 2024 06:04 AM Form EFFECT NewAmsterdam Pharma Co
Apr 12, 2024 04:16 PM Form POS AM NewAmsterdam Pharma Co
Apr 9, 2024 08:00 AM BioAge Appoints Renowned Cardiologist and Biopharma Entrepreneur Michael H. Davidson, MD, to its Board of Directors
Apr 9, 2024 08:00 AM NewAmsterdam Pharma Enrolls Over 9,000 Patients in Pivotal Phase 3 PREVAIL Global Cardiovascular Outcome Trial Evaluating the Effect of Obicetrapib in Patients with Established Atherosclerotic Cardiov
Apr 2, 2024 04:30 PM Form 4 NewAmsterdam Pharma Co For: Apr 01 Filed by: Audet Juliette Berangere
Apr 1, 2024 08:16 AM Form 8-K NewAmsterdam Pharma Co For: Mar 28
Apr 1, 2024 08:06 AM NewAmsterdam Pharma (NAMS) Appoints Juliette Audet as Chief Business Officer
Apr 1, 2024 08:00 AM NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Mar 28, 2024 04:35 PM Form 4 NewAmsterdam Pharma Co For: Mar 26 Filed by: Topper James N

Entities mentioned with NAMS